Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Montevialeon Feb 01, 2018 11:12pm
138 Views
Post# 27486219

RE:Fooey on the FDA Sessions and Big Pharma.

RE:Fooey on the FDA Sessions and Big Pharma.Fooey...did you read the updated article.  Aphria isn't pulling out of the USA.  They are reorganizing how they hold Cooperstate inorder to keep the TSX happy.  

canucks444 wrote: I for one am glad Aphria pulled out of the US. Lets face it big money controls everything and you dont get much bigger than the drug industry. I bet they are behind jeff sessions marijuana crusade. There is great resistance from the pharmaceuticals down there. There worst nightmare that marijuana cures cancer. There have been studys that have found the active compounds in marijuana, cannabidiol, exerts a cancer-preventive effect in mice. Purdue Pharma and Abbott Laboratories, makers of the painkiller OxyContin and Vicodin, respectively, are among the largest contributors to the Anti-Drug(canmnabis) Coalition of America, according to a report in the Nation. And the Pharmaceutical Research and Manufacturers of America, considered one of marijuanas biggest opponents, spent nearly $19m on lobbying in 2015. The existing legal grey area makes it hard for marijuana operations that struggle with a wide range of hurdles, such as banking challenges, law enforcement conflicts and contradictory laws. But current pot restrictions are good for pharmaceutical companies that have the resources and infrastructure to navigate Food and Drug Administration approvals.


Bullboard Posts